ALVO
Alvotech Health Care Biological Products, (No Diagnostic Substances) Russell 3000
$4.65Close
$3.00 – $7.8452-week range
Nov 11, 2026Next report · after the close
Highlights
Strengths
- Accumulation up-day volume 1.7× down-day volume over 50 sessions
Cautions
- Not in an uptrend 4 of 8 trend conditions
- Far from its high 41% below its 52-week high
- Results soon Nov 11, 2026, in 10 days
Price
Filing Results Screen pick 52-week high and low Adjusted prices
Trade setup
ATR%
5.9%
$0.28 a day · 2×ATR $4.10
RS
53 / 99
vs the universe
Trend
4 / 8
trend template
Relative volume
0.6×
vs 50-day average
Up/down volume
1.67
50 sessions
Implied move
—
no option chain · report Nov 11, 2026
Trend template · 4 of 8
- Price above the 150 and 200-day averages: passes
- 150-day average above the 200-day: fails
- 200-day average rising for a month: passes
- 50-day average above the 150 and 200-day: passes
- Price above the 50-day average: fails
- At least 30% above the 52-week low: passes
- Within 25% of the 52-week high: fails
- RS rank 70 or higher: fails
Screen verdict
Not scorable — no classified balance sheet.
Filings
| Filed | Report | Period to | Lag |
|---|---|---|---|
| Mar 31, 2026 | Annual ↗ | — | 0d |
| Mar 27, 2025 | Annual ↗ | — | 0d |
| Mar 20, 2024 | Annual ↗ | — | 0d |
| Mar 1, 2023 | Annual ↗ | — | 0d |
Current reports
| Filed | Disclosed |
|---|---|
| Oct 20, 2026 | Foreign issuer report ↗ |
| Oct 14, 2026 | Foreign issuer report ↗ |
| Oct 7, 2026 | Foreign issuer report ↗ |
| Oct 5, 2026 | Foreign issuer report ↗ |
| Aug 31, 2026 | Foreign issuer report ↗ |
| Aug 21, 2026 | Foreign issuer report ↗ |
| Aug 19, 2026 | Foreign issuer report ↗ |
| Jul 29, 2026 | Foreign issuer report ↗ |
| Jul 1, 2026 | Foreign issuer report ↗ |
| Jun 18, 2026 | Foreign issuer report ↗ |
| Jun 17, 2026 | Foreign issuer report ↗ |
| Jun 15, 2026 | Foreign issuer report ↗ |